These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18231653)

  • 21. [Efficiency of lymphocytes adhesion to endothelial cells of distinct tissue origin from children with asthma].
    Lewandowicz-Uszyńska A; Paprocka M; Kieda C; Duś D
    Pol Merkur Lekarski; 2004 Feb; 16(92):104-7. PubMed ID: 15176289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of enzymatically-digested hyaluronan by liver endothelial cells in vivo and in vitro.
    Mochizuki S; Kano A; Shimada N; Maruyama A
    J Biomater Sci Polym Ed; 2009; 20(1):83-97. PubMed ID: 19105902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding.
    Lesley J; English N; Charles C; Hyman R
    Eur J Immunol; 2000 Jan; 30(1):245-53. PubMed ID: 10602047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
    Zhu D; Bourguignon LY
    J Cell Physiol; 2000 May; 183(2):182-95. PubMed ID: 10737894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging role of CD44 in regulating skeletal micrometastasis.
    Hill A; McFarlane S; Johnston PG; Waugh DJ
    Cancer Lett; 2006 Jun; 237(1):1-9. PubMed ID: 15979783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding.
    Päll T; Gad A; Kasak L; Drews M; Strömblad S; Kogerman P
    Oncogene; 2004 Oct; 23(47):7874-81. PubMed ID: 15361838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronan and its receptors in mucoepidermoid carcinoma.
    Wein RO; McGary CT; Doerr TD; Popat SR; Howard JL; Weigel JA; Weigel PH
    Head Neck; 2006 Feb; 28(2):176-81. PubMed ID: 16355387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
    Mizrahy S; Raz SR; Hasgaard M; Liu H; Soffer-Tsur N; Cohen K; Dvash R; Landsman-Milo D; Bremer MG; Moghimi SM; Peer D
    J Control Release; 2011 Dec; 156(2):231-8. PubMed ID: 21745506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting hyaluronan of the endothelial glycocalyx for therapeutic intervention.
    Wheeler-Jones CP; Farrar CE; Pitsillides AA
    Curr Opin Investig Drugs; 2010 Sep; 11(9):997-1006. PubMed ID: 20730694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel ligand blot assay detects different hyaluronan-binding proteins in rat liver hepatocytes and sinusoidal endothelial cells.
    Yannariello-Brown J; Zhou B; Ritchie D; Oka JA; Weigel PH
    Biochem Biophys Res Commun; 1996 Jan; 218(1):314-9. PubMed ID: 8573153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution and expression of CD44 isoforms and Ezrin during prostate cancer-endothelium interaction.
    Harrison GM; Davies G; Martin TA; Jiang WG; Mason MD
    Int J Oncol; 2002 Nov; 21(5):935-40. PubMed ID: 12370738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chondroitin sulfate addition to CD44H negatively regulates hyaluronan binding.
    Ruffell B; Johnson P
    Biochem Biophys Res Commun; 2005 Aug; 334(2):306-12. PubMed ID: 16002044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGFbeta1 is involved in high glucose-induced accumulation of pericellular chondroitin sulphate in human endothelial cells.
    Yevdokimova NY; Komisarenko SV
    J Diabetes Complications; 2004; 18(5):300-8. PubMed ID: 15337504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour regulation of fibroblast hyaluronan expression: a mechanism to facilitate tumour growth and invasion.
    Edward M; Gillan C; Micha D; Tammi RH
    Carcinogenesis; 2005 Jul; 26(7):1215-23. PubMed ID: 15746159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of iodinated hyaluronan derivatives to study hyaluronan binding, endocytosis, and metabolism by cultured cells.
    Weigel PH; McGary CT; Weigel JA
    Methods Enzymol; 2003; 363():382-91. PubMed ID: 14579591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of CD44 in canine melanocytic tumours.
    Serra M; Rabanal RM; Miquel L; Domenzain C; Bassols A
    J Comp Pathol; 2004; 130(2-3):171-80. PubMed ID: 15003475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells.
    Subramaniam V; Gardner H; Jothy S
    Exp Mol Pathol; 2007 Dec; 83(3):341-6. PubMed ID: 17945213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyaluronic acid, receptor CD44, and their role in diabetic complications].
    Ievdokimova NIu
    Ukr Biokhim Zh (1999); 2008; 80(5):5-44. PubMed ID: 19248616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
    Hanley WD; Burdick MM; Konstantopoulos K; Sackstein R
    Cancer Res; 2005 Jul; 65(13):5812-7. PubMed ID: 15994957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Origin and function of circulating CD44 in non-Hodgkin's lymphoma.
    Ristämaki R; Joensuu H; Grön-Virta K; Salmi M; Jalkanen S
    J Immunol; 1997 Mar; 158(6):3000-8. PubMed ID: 9058839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.